Interest Expense in USD of CARDINAL HEALTH INC from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
CARDINAL HEALTH INC quarterly/annual Interest Expense history and change rate from Q1 2010 to Q3 2025.
  • CARDINAL HEALTH INC Interest Expense for the quarter ending 30 Sep 2025 was $80,000,000.000, a 150% increase year-over-year.
  • CARDINAL HEALTH INC Interest Expense for the twelve months ending 30 Sep 2025 was $263,000,000.000, a 265% increase year-over-year.
  • CARDINAL HEALTH INC annual Interest Expense for 2025 was $215,000,000.000, a 322% increase from 2024.
  • CARDINAL HEALTH INC annual Interest Expense for 2024 was $51,000,000.000, a 39.3% decline from 2023.
  • CARDINAL HEALTH INC annual Interest Expense for 2023 was $84,000,000.000, a 42.9% decline from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

CARDINAL HEALTH INC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $263,000,000 $80,000,000 +$48,000,000 +1.5% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $215,000,000 $74,000,000 +$65,000,000 +7.2% 01 Apr 2025 30 Jun 2025 10-K 12 Aug 2025
Q1 2025 $150,000,000 $74,000,000 +$46,000,000 +1.6% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $104,000,000 $35,000,000 +$32,000,000 +10.7% 01 Oct 2024 31 Dec 2024 10-Q 30 Jan 2025
Q3 2024 $72,000,000 $32,000,000 +$21,000,000 +1.9% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $51,000,000 $9,000,000 -$1,000,000 -10% 01 Apr 2024 30 Jun 2024 10-K 12 Aug 2025
Q1 2024 $52,000,000 $28,000,000 +$2,000,000 +7.7% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $50,000,000 $3,000,000 -$21,000,000 -87.5% 01 Oct 2023 31 Dec 2023 10-Q 30 Jan 2025
Q3 2023 $71,000,000 $11,000,000 -$13,000,000 -54.2% 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2024
Q2 2023 $84,000,000 $10,000,000 -$22,000,000 -68.8% 01 Apr 2023 30 Jun 2023 10-K 12 Aug 2025
Q1 2023 $106,000,000 $26,000,000 -$12,000,000 -31.6% 01 Jan 2023 31 Mar 2023 10-K 14 Aug 2024
Q4 2022 $118,000,000 $24,000,000 -$13,000,000 -35.1% 01 Oct 2022 31 Dec 2022 10-K 14 Aug 2024
Q3 2022 $131,000,000 $24,000,000 -$16,000,000 -40% 01 Jul 2022 30 Sep 2022 10-K 14 Aug 2024
Q2 2022 $147,000,000 $32,000,000 -$12,000,000 -27.3% 01 Apr 2022 30 Jun 2022 10-K 14 Aug 2024
Q1 2022 $159,000,000 $38,000,000 -$7,000,000 -15.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $166,000,000 $37,000,000 -$9,000,000 -19.6% 01 Oct 2021 31 Dec 2021 10-Q 02 Feb 2023
Q3 2021 $175,000,000 $40,000,000 -$5,000,000 -11.1% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022
Q2 2021 $180,000,000 $44,000,000 -$5,000,000 -10.2% 01 Apr 2021 30 Jun 2021 10-K 15 Aug 2023
Q1 2021 $185,000,000 $45,000,000 -$15,000,000 -25% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $200,000,000 $46,000,000 -$17,000,000 -27% 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022
Q3 2020 $217,000,000 $45,000,000 -$21,000,000 -31.8% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $238,000,000 $49,000,000 -$17,000,000 -25.8% 01 Apr 2020 30 Jun 2020 10-K 11 Aug 2022
Q1 2020 $255,000,000 $60,000,000 -$15,000,000 -20% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $270,000,000 $63,000,000 -$13,000,000 -17.1% 01 Oct 2019 31 Dec 2019 10-Q 05 Feb 2021
Q3 2019 $283,000,000 $66,000,000 -$11,000,000 -14.3% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $294,000,000 $66,000,000 -$11,000,000 -14.3% 01 Apr 2019 30 Jun 2019 10-K 16 Aug 2021
Q1 2019 $305,000,000 $75,000,000 -$9,000,000 -10.7% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $314,000,000 $76,000,000 -$11,000,000 -12.6% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020
Q3 2018 $325,000,000 $77,000,000 -$4,000,000 -4.9% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 $329,000,000 $77,000,000 +$10,000,000 +14.9% 01 Apr 2018 30 Jun 2018 10-K 13 Aug 2020
Q1 2018 $319,000,000 $84,000,000 +$38,000,000 +82.6% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $281,000,000 $87,000,000 +$43,000,000 +97.7% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 $238,000,000 $81,000,000 +$37,000,000 +84.1% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 $201,000,000 $67,000,000 +$22,000,000 +48.9% 01 Apr 2017 30 Jun 2017 10-K 20 Aug 2019
Q1 2017 $179,000,000 $46,000,000 +$2,000,000 +4.5% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $177,000,000 $44,000,000 -$1,000,000 -2.2% 01 Oct 2016 31 Dec 2016 10-Q 08 Feb 2018
Q3 2016 $178,000,000 $44,000,000 $0 0% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 $178,000,000 $45,000,000 +$9,000,000 +25% 01 Apr 2016 30 Jun 2016 10-K 22 Aug 2018
Q1 2016 $169,000,000 $44,000,000 +$9,000,000 +25.7% 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017
Q4 2015 $160,000,000 $45,000,000 +$9,000,000 +25% 01 Oct 2015 31 Dec 2015 10-Q 07 Feb 2017
Q3 2015 $151,000,000 $44,000,000 +$10,000,000 +29.4% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016
Q2 2015 $141,000,000 $36,000,000 +$3,000,000 +9.1% 01 Apr 2015 30 Jun 2015 10-K 10 Aug 2017
Q1 2015 $138,000,000 $35,000,000 +$1,000,000 +2.9% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016
Q4 2014 $137,000,000 $36,000,000 +$3,000,000 +9.1% 01 Oct 2014 31 Dec 2014 10-Q 02 Feb 2016
Q3 2014 $134,000,000 $34,000,000 +$1,000,000 +3% 01 Jul 2014 30 Sep 2014 10-Q 03 Nov 2015
Q2 2014 $133,000,000 $33,000,000 -$3,000,000 -8.3% 01 Apr 2014 30 Jun 2014 10-K 12 Aug 2016
Q1 2014 $136,000,000 $34,000,000 $0 0% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015
Q4 2013 $136,000,000 $33,000,000 +$6,000,000 +22.2% 01 Oct 2013 31 Dec 2013 10-Q 03 Feb 2015
Q3 2013 $130,000,000 $33,000,000 +$7,000,000 +26.9% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014
Q2 2013 $123,000,000 $36,000,000 +$11,000,000 +44% 01 Apr 2013 30 Jun 2013 10-K 13 Aug 2015
Q1 2013 $112,000,000 $34,000,000 +$10,000,000 +41.7% 01 Jan 2013 31 Mar 2013 10-Q 06 May 2014
Q4 2012 $102,000,000 $27,000,000 +$4,000,000 +17.4% 01 Oct 2012 31 Dec 2012 10-Q 06 Feb 2014
Q3 2012 $98,000,000 $26,000,000 +$3,000,000 +13% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013
Q2 2012 $95,000,000 $25,000,000 +$1,000,000 +4.2% 01 Apr 2012 30 Jun 2012 10-K 13 Aug 2014
Q1 2012 $94,000,000 $24,000,000 -$1,100,000 -4.4% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013
Q4 2011 $95,100,000 $23,000,000 +$1,100,000 +5% 01 Oct 2011 31 Dec 2011 10-Q 06 Feb 2013
Q3 2011 $94,000,000 $23,000,000 +$1,000,000 +4.5% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $93,000,000 $24,000,000 01 Apr 2011 30 Jun 2011 10-K 20 Aug 2013
Q1 2011 $25,100,000 -$2,600,000 -9.4% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012
Q4 2010 $21,900,000 01 Oct 2010 31 Dec 2010 10-Q 07 Feb 2012
Q3 2010 $22,000,000 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011
Q1 2010 $27,700,000 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011

CARDINAL HEALTH INC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $215,000,000 +$164,000,000 +3.2% 01 Jul 2024 30 Jun 2025 10-K 12 Aug 2025
2024 $51,000,000 -$33,000,000 -39.3% 01 Jul 2023 30 Jun 2024 10-K 12 Aug 2025
2023 $84,000,000 -$63,000,000 -42.9% 01 Jul 2022 30 Jun 2023 10-K 12 Aug 2025
2022 $147,000,000 -$33,000,000 -18.3% 01 Jul 2021 30 Jun 2022 10-K 14 Aug 2024
2021 $180,000,000 -$58,000,000 -24.4% 01 Jul 2020 30 Jun 2021 10-K 15 Aug 2023
2020 $238,000,000 -$56,000,000 -19% 01 Jul 2019 30 Jun 2020 10-K 11 Aug 2022
2019 $294,000,000 -$35,000,000 -10.6% 01 Jul 2018 30 Jun 2019 10-K 16 Aug 2021
2018 $329,000,000 +$128,000,000 +63.7% 01 Jul 2017 30 Jun 2018 10-K 13 Aug 2020
2017 $201,000,000 +$23,000,000 +12.9% 01 Jul 2016 30 Jun 2017 10-K 20 Aug 2019
2016 $178,000,000 +$37,000,000 +26.2% 01 Jul 2015 30 Jun 2016 10-K 22 Aug 2018
2015 $141,000,000 +$8,000,000 +6% 01 Jul 2014 30 Jun 2015 10-K 10 Aug 2017
2014 $133,000,000 +$10,000,000 +8.1% 01 Jul 2013 30 Jun 2014 10-K 12 Aug 2016
2013 $123,000,000 +$28,000,000 +29.5% 01 Jul 2012 30 Jun 2013 10-K 13 Aug 2015
2012 $95,000,000 +$2,000,000 +2.2% 01 Jul 2011 30 Jun 2012 10-K 13 Aug 2014
2011 $93,000,000 -$20,000,000 -17.7% 01 Jul 2010 30 Jun 2011 10-K 20 Aug 2013
2010 $113,000,000 01 Jul 2009 30 Jun 2010 10-K 22 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.